Teri E. Klein
Impact in
- Pharmacology top 0.01%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Adverse Reactions
- Genetics top 0.5%
- Genomics and Rare Diseases
- Genetic Associations and Epidemiology
Papers in
- Pharmacology 218
- Pharmacogenetics and Drug Metabolism 218
- Drug-Induced Adverse Reactions 4
- Genetics 26
- Genomics and Rare Diseases 16
- Connective tissue disorders research 9
- Co-authors
- Russ Biagio Altman (147 shared papers)Michelle Whirl‐Carrillo (91 shared papers)Katrin Sangkuhl (59 shared papers)Caroline F. Thorn (45 shared papers)Mary V. Relling (27 shared papers)Li Gong (50 shared papers)Andrea Gaedigk (40 shared papers)Kelly E. Caudle (42 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (100 papers)Pharmacogenetics and Genomics (92 papers)Genetics in Medicine (13 papers)Human Mutation (5 papers)Pharmacogenomics (5 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Teri E. Klein
348 papers receiving 37.0k citations
Teri E. Klein's Hit Papers
Peers
Comparison fields: 5 of 162
- Pharmacology 17.8k
- Genetics 2.7k
- Transplantation 207
- Pharmacology 776
- Cardiology and Cardiovascular Medicine 1.4k
Countries citing papers authored by Teri E. Klein
This map shows the geographic impact of Teri E. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teri E. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teri E. Klein more than expected).
Fields of papers citing papers by Teri E. Klein
This network shows the impact of papers produced by Teri E. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teri E. Klein. The network helps show where Teri E. Klein may publish in the future.
Co-authors
The 25 scholars most cited alongside Teri E. Klein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 355 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacogenomics Knowledge for Personalized Medicine Hit paper breakdown → | 2012 | 1444 |
| 2 | Doxorubicin pathways Hit paper breakdown → | 2010 | 1396 |
| 3 | Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics Hit paper breakdown → | 2016 | 1312 |
| 4 | Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes Hit paper breakdown → | 2012 | 1022 |
| 5 | CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network Hit paper breakdown → | 2011 | 912 |
| 6 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors Hit paper breakdown → | 2015 | 786 |
| 7 | Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update Hit paper breakdown → | 2013 | 780 |
| 8 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing Hit paper breakdown → | 2015 | 574 |
| 9 | Clinical assessment incorporating a personal genome Hit paper breakdown → | 2010 | 557 |
| 10 | Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update Hit paper breakdown → | 2014 | 546 |
| 11 | Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing Hit paper breakdown → | 2011 | 537 |
| 12 | Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update Hit paper breakdown → | 2016 | 535 |
| 13 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update Hit paper breakdown → | 2017 | 526 |
| 14 | An Evidence‐Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine Hit paper breakdown → | 2021 | 520 |
| 15 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update Hit paper breakdown → | 2017 | 507 |
| 16 | Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT 15 Genotypes: 2018 Update Hit paper breakdown → | 2018 | 506 |
| 17 | Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing Hit paper breakdown → | 2011 | 472 |
| 18 | Standardizing CYP 2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group Hit paper breakdown → | 2019 | 418 |
| 19 | Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC) Hit paper breakdown → | 2016 | 417 |
| 20 | Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy Hit paper breakdown → | 2011 | 410 |
About Teri E. Klein
Teri E. Klein is a scholar working on Pharmacology, Genetics, Computational Theory and Mathematics, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 355 papers that have together received 38.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (218 papers), Genomics and Rare Diseases (16 papers), Computational Drug Discovery Methods (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Connective tissue disorders research (9 papers), Protein Structure and Dynamics (6 papers), Biomedical Text Mining and Ontologies (5 papers) and Drug-Induced Adverse Reactions (4 papers). The work is most often cited by research in Pharmacology (17.8k citations), Genetics (2.7k citations), Transplantation (207 citations), Pharmacology (776 citations) and Cardiology and Cardiovascular Medicine (1.4k citations). Teri E. Klein has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Russ Biagio Altman, Michelle Whirl‐Carrillo, Katrin Sangkuhl, Caroline F. Thorn, Mary V. Relling, Li Gong, Andrea Gaedigk, Kelly E. Caudle, Stuart A. Scott and Howard L. McLeod. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Pharmacogenetics and Genomics, Genetics in Medicine, Human Mutation and Pharmacogenomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.